Literature DB >> 34508482

Carcinosarcoma of the Cervix: A Case Report.

Birendra Bhagat1, Bijaya Chandra Aacharya2, Sarita Gurung2, Ranjan Raj Bhatta3, Aasiya Rajbhandari4.   

Abstract

Cervical carcinoma is the most common cause of mortality due to cancer in Nepal. Carcinosarcoma is a very rare subtype of cervical cancer which is characterized by the presence of both epithelial and mesenchymal malignant component. It constitutes less than 1% of cervical carcinoma. Due to the low occurrence of the disease, most of the data on treatment and prognosis are based on case reports and series. Here, we report a case of 69 years, female with cervical cancer (FIGO IIA2). Histopathological and immunohistochemical analysis of cervical biopsy initially showed primary adenosarcoma of the cervix. The tumor was non-responsive to primary treatment with concurrent chemoradiation. Later she was treated with abdominal hysterectomy and bilateral salpingo-oophorectomy. The final histopathology of the resected specimen showed a sarcomatous component along with carcinomatous changes in the endocervical glands favouring the diagnosis of carcinosarcoma of the cervix.

Entities:  

Mesh:

Year:  2021        PMID: 34508482      PMCID: PMC9107833          DOI: 10.31729/jnma.6566

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.556


  8 in total

1.  Carcinosarcoma of the uterine cervix: a rare pathological finding originating from mesonephric remnants.

Authors:  Bárbara Ribeiro; Raquel Silva; Renata Dias; Vanda Patrício
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 2.  Therapy Modalities, Prognostic Factors, and Outcome of the Primary Cervical Carcinosarcoma: Meta-analysis of Extremely Rare Tumor of Cervix.

Authors:  Gunsu Kimyon Comert; Osman Turkmen; Alper Karalok; Derman Basaran; Dilek Bulbul; Taner Turan
Journal:  Int J Gynecol Cancer       Date:  2017-11       Impact factor: 3.437

3.  Sarcoma of the cervix: natural history and outcomes.

Authors:  Sharmilee Bansal; Sharyn N Lewin; William M Burke; Israel Deutsch; Xuming Sun; Thomas J Herzog; Jason D Wright
Journal:  Gynecol Oncol       Date:  2010-06-11       Impact factor: 5.482

Review 4.  Uterine carcinosarcoma.

Authors:  Rebecca Arend; Janine A Doneza; Jason D Wright
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

Review 5.  Review of Recommended Treatment of Uterine Carcinosarcoma.

Authors:  Joseph Menczer
Journal:  Curr Treat Options Oncol       Date:  2015-11

6.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

7.  Carcinosarcoma of the uterine cervix: case report and discussion.

Authors:  Rosa Laterza; Anna Seveso; Francesca Zefiro; Giorgio Formenti; Luca Mellana; Nicoletta Donadello; Fabio Ghezzi; Pierfrancesco Bolis; Cristina Riva
Journal:  Gynecol Oncol       Date:  2007-08-28       Impact factor: 5.482

Review 8.  Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.

Authors:  P B Clement; J T Zubovits; R H Young; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1998-07       Impact factor: 2.762

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.